Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-25-100854
Filing Date
2025-10-20
Accepted
2025-10-20 16:31:18
Documents
17

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2529020d1_s1.htm S-1 519802
2 EXHIBIT 5.1 tm2529020d1_ex5-1.htm EX-5.1 10285
3 EXHIBIT 23.2 tm2529020d1_ex23-2.htm EX-23.2 1980
4 EX-FILING FEES tm2529020d1_ex-filingfees.htm   iXBRL EX-FILING FEES 25702
5 GRAPHIC tm2529020d1_ex5-1img001.jpg GRAPHIC 5501
6 GRAPHIC tm2529020d1_s1img001.jpg GRAPHIC 9377
7 GRAPHIC tm2529020d1_s1img002.jpg GRAPHIC 38029
  Complete submission text file 0001104659-25-100854.txt   754772

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2529020d1_ex-filingfees_htm.xml XML 5075
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-290971 | Film No.: 251404277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)